Autopsy report · NCT00721097

Predictive Factors for Exacerbation Outcome in Severe Refractory Asthmatics

“Number of included patients is sufficient.”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 2 years 11 months before it stopped.
• 40 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

Nantes University Hospital

Sponsor type

University, hospital or other

Conditions

Asthma; Chronic Inflammatory Diseases

Interventions

spirometry, and blood taken

Participants

40

Sites

1

Countries

France

Trials that died the same way

• Epidermal Cells Delivery and Acute Burns
  “Not enough patients included” (79% match in meaning)
• Short Spot Versus Long Lesion Stenting as Best Treatment for Extensive Occlusive SFA Disease
  “Unable to include the number of patients” (77% match in meaning)
• Duration of Postoperative Antibiotic Prophylaxis in Facial Fractures
  “Limited number of patients” (77% match in meaning)
• Pyrexia Management Using an IL-6 Antibody in BRAF+ Melanoma Patients Treated with Dabrafenib/ Trametinib +/- Immunotherapy
  “too few patients could be included” (77% match in meaning)
• The Antidepressant Effect of Right Temporal Low Frequency rTMS Compared to Sham
  “Too few patients included” (76% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.